Confident Investing Starts With TipRanks Premium

Get 55% Off
TipRanks
Go Ultimate55% OFF

Sinopharm Group Co (SHTDY) Stock Price & Analysis

SHTDY Stock Chart & Stats

$10.32$0.18(1.73%)
At close: 4:00 PM EDT
$9.5$10$10.5$1128 Jul10 Aug24 Aug4 Sep16 Sep9 Oct
Day’s Range
$10.32 - $10.32
52-Week Range
$9.37 - $14.04
Previous Close
$10.14
Volume
67.41K
Average Volume (3M)
5,938
Market Cap
$6.44B
Enterprise Value
$23.42B
Total Cash (Recent Filing)
$41.90B
Total Debt (Recent Filing)
$81.32B
Price to Earnings (P/E)
6.1
Beta
0.08
Next Earnings
Mar 19, 2027 (Est.)
EPS Estimate
N/A
Last Dividend Ex-Date
Jun 24, 2026
Dividend Yield
4.87%

Bulls Say, Bears Say

Bulls Say

Nationwide Healthcare Distribution Network

A nationwide distribution network serving institutional and retail healthcare customers gives Sinopharm broad commercial reach and supports recurring product flow across multiple channels. This scale can reinforce customer access and make the core distribution model durable over the next several quarters.

Consistent Cash Conversion

Positive operating and free cash flow, together with substantial conversion of reported earnings into cash, indicates that profits are generally supported by cash generation. That provides an important foundation for funding operations and maintaining financial resilience despite weaker recent momentum.

Broad Healthcare Product Portfolio

Exposure across pharmaceuticals, devices, diagnostics, consumables, retail pharmacy, and supply-chain services diversifies Sinopharm’s healthcare offering. A broad portfolio allows the company to serve several provider types and product categories rather than relying on a single revenue stream.

Bears Say

Recent Revenue Contraction

Recent revenue contraction shows that the company’s earlier growth has not continued consistently. A declining top line can reduce operating leverage, limit investment capacity, and make it harder for Sinopharm to offset cost pressures through higher volume over the next several quarters.

Structural Margin Compression

Falling gross and EBITDA margins indicate that less profit is being retained from each unit of distribution activity. Because net margin is already thin, sustained margin pressure leaves limited room to absorb pricing, procurement, or operating-cost changes without affecting earnings.

Higher Leverage And Lower Returns

The sharp increase in debt relative to equity raises financial risk and reduces flexibility compared with the prior year. Combined with lower returns on equity, higher leverage may constrain capital allocation and make the business more sensitive to weaker profitability or cash-flow conditions.

Sinopharm Group Co News

SHTDY FAQ

What was Sinopharm Group Co’s price range in the past 12 months?
Sinopharm Group Co lowest stock price was $9.37 and its highest was $14.04 in the past 12 months.
What is Sinopharm Group Co’s market cap?
Sinopharm Group Co’s market cap is $6.44B.
When is Sinopharm Group Co’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Sinopharm Group Co’s earnings last quarter?
Sinopharm Group Co released its earnings results on Aug 23, 2026. The company reported $0.795 earnings per share for the quarter.
Is Sinopharm Group Co overvalued?
Not enough analysts have published a price target to calculate whether the price is overvalued.
Does Sinopharm Group Co pay dividends?
Sinopharm Group Co pays a Annually dividend of $0.503 which represents an annual dividend yield of 4.87%. See more information on Sinopharm Group Co dividends here
What is Sinopharm Group Co’s EPS estimate?
Sinopharm Group Co’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Sinopharm Group Co have?
Sinopharm Group Co has 268,362,150 shares outstanding.
What happened to Sinopharm Group Co’s price movement after its last earnings report?
Sinopharm Group Co reported an EPS of $0.795 in its last earnings report. Following the earnings report the stock price went up 0.102%.
Which hedge fund is a major shareholder of Sinopharm Group Co?
Currently, no hedge funds are holding shares in SHTDY
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology